[Go-diff] GO update 02/18/2009

[Remote CVS for Gene Ontology]

OBODIFF of gene_ontology_write.obo version 1.447 by 1.449

Starting obodiff at /share/go/bin/oboedit/current using 256M of memory
* Created object of type obo:TERM with id GO:0010901
* Created object of type obo:TERM with id GO:0010902
* Created object of type obo:TERM with id GO:0010903
* Populated new object GO:0010901 (macro)
  * Changed name of GO:0010901 from "<new term>" to "regulation of very-low-density lipoprotein particle remodeling"
  * Set definition of GO:0010901 to "Any process that modulates the rate, frequency or extent of very-low-density lipoprotein particle remodeling. Very-low-density lipoprotein particle remodeling is the acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid."
  * Added definition dbxref GOC:tb to GO:0010901
  * Added synonym "regulation of VLDL remodeling" to GO:0010901
  * Added general dbxref GOC:tb to synonym regulation of VLDL remodeling of GO:0010901
  * Changed synonym scope of GO:0010901 from "Related" to "Exact"
  * Copied GO:0010901 to GO:0034372 with type regulates
  * Copied GO:0010901 to GO:0051128 with type OBO_REL:is_a
  * Assigned namespace "biological_process" to GO:0010901
* Populated new object GO:0010902 (macro)
  * Changed name of GO:0010902 from "<new term>" to "positive regulation of very-low-density lipoprotein particle remodeling"
  * Set definition of GO:0010902 to "Any process that increases the rate, frequency or extent of very-low-density lipoprotein particle remodeling. Very-low-density lipoprotein particle remodeling is the acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid."
  * Added definition dbxref GOC:tb to GO:0010902
  * Added synonym "positive regulation of VLDL remodeling" to GO:0010902
  * Added general dbxref GOC:tb to synonym positive regulation of VLDL remodeling of GO:0010902
  * Changed synonym scope of GO:0010902 from "Related" to "Exact"
  * Copied GO:0010902 to GO:0034372 with type positively_regulates
  * Copied GO:0010902 to GO:0051130 with type OBO_REL:is_a
  * Copied GO:0010902 to GO:0010901 with type OBO_REL:is_a
  * Assigned namespace "biological_process" to GO:0010902
* Populated new object GO:0010903 (macro)
  * Changed name of GO:0010903 from "<new term>" to "negative regulation of very-low-density lipoprotein particle remodeling"
  * Set definition of GO:0010903 to "Any process that decreases the rate, frequency or extent of very-low-density lipoprotein particle remodeling. Very-low-density lipoprotein particle remodeling is the acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid."
  * Added definition dbxref GOC:tb to GO:0010903
  * Added synonym "negative regulation of VLDL remodeling" to GO:0010903
  * Added general dbxref GOC:tb to synonym negative regulation of VLDL remodeling of GO:0010903
  * Changed synonym scope of GO:0010903 from "Related" to "Exact"
  * Copied GO:0010903 to GO:0034372 with type negatively_regulates
  * Copied GO:0010903 to GO:0010901 with type OBO_REL:is_a
  * Copied GO:0010903 to GO:0051129 with type OBO_REL:is_a
  * Assigned namespace "biological_process" to GO:0010903
* Deleted synonym "ubiquitin-activating enzyme" from GO:0004842
* Set definition of GO:0004935 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity."
* Added definition dbxref GOC:mah to GO:0004935
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0004935
* Set definition of GO:0004936 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of alpha-adrenergic receptors."
* Added definition dbxref GOC:mah to GO:0004936
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0004936
* Set definition of GO:0004937 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of alpha1-adrenergic receptors."
* Added definition dbxref GOC:mah to GO:0004937
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0004937
* Set definition of GO:0004938 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of alpha2-adrenergic receptors."
* Added definition dbxref GOC:mah to GO:0004938
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0004938
* Set definition of GO:0004939 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta-adrenergic receptors."
* Added definition dbxref GOC:mah to GO:0004939
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0004939
* Set definition of GO:0004940 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta1-adrenergic receptors."
* Added definition dbxref GOC:mah to GO:0004940
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0004940
* Set definition of GO:0004941 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta2-adrenergic receptors."
* Added definition dbxref GOC:mah to GO:0004941
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0004941
* Set definition of GO:0004981 to "Combining with acetylcholine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of muscarinic receptors."
* Added definition dbxref GOC:mah to GO:0004981
* Added definition dbxref IUPHAR_GPCR:1271 to GO:0004981
* Changed definition of GO:0006903 from "The process by which vesicles are directed to specific destination membranes. Targeting involves coordinatet interactions among cytoskeletal elements (microtubules or actin filaments), motor proteins, molecules at the vesicle membrane and target membrane surfaces, and vesicle cargo." to "The process by which vesicles are directed to specific destination membranes. Targeting involves coordinated interactionsg among cytoskeletal elements (microtubules or actin filaments), motor proteins, molecules at the vesicle membrane and target membrane surfaces, and vesicle cargo."
* Deleted GO:0010899 --positively_regulates--> GO:0034638
* Set definition of GO:0015052 to "Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta3-adrenergic receptors."
* Added definition dbxref GOC:mah to GO:0015052
* Added definition dbxref IUPHAR_GPCR:1274 to GO:0015052
* Set definition of GO:0016907 to "Combining with acetylcholine to initiate a change in cell activity via activation of a G protein."
* Added definition dbxref GOC:mah to GO:0016907
* Deleted GO:0032847 --OBO_REL:is_a--> GO:0051452
* Deleted GO:0070304 --positively_regulates--> GO:0070302
* Changed definition of GO:0070375 from "A cascade of protein kinase activities, culminating in the phosphorylation and activation of big MAP kinase (BMK1/ERK5), which is a type of mitogen-activated protein (MAP) kinases." to "A cascade of protein kinase activities, culminating in the phosphorylation and activation of big MAP kinase (BMK1/ERK5), which is a type of mitogen-activated protein (MAP) kinase."
* Changed name of GO:0070384 from "harderian gland development" to "Harderian gland development"
* Changed comment from "Note that the harderian gland is found in all terrestrial vertebrate groups, including amphibia, reptiles, birds, and mammals. However, it appears to be absent in certain mammals such as bats, cows, horses, and higher primates. Though largely absent in the adult human, it is present in the fetal and neonatal stages." to "Note that the Harderian gland is found in all terrestrial vertebrate groups, including amphibia, reptiles, birds, and mammals. However, it appears to be absent in certain mammals such as bats, cows, horses, and higher primates. Though largely absent in the adult human, it is present in the fetal and neonatal stages."
* Changed definition of GO:0070384 from "The process whose specific outcome is the progression of the harderian gland over time, from its formation to the mature structure. The harderian gland is an anterior orbital structure usually associated with the nictitating membrane, and produces and secretes a variety of substances to the eye, depending upon the species." to "The process whose specific outcome is the progression of the Harderian gland over time, from its formation to the mature structure. The Harderian gland is an anterior orbital structure usually associated with the nictitating membrane, and produces and secretes a variety of substances to the eye, depending upon the species."